These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29119461)

  • 21. Using genomic data to make indirect (and unauthorized) estimates of disease risk.
    Nyholt DR
    Public Health Genomics; 2012; 15(5):303-11. PubMed ID: 22722694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
    Talwar P; Sinha J; Grover S; Rawat C; Kushwaha S; Agarwal R; Taneja V; Kukreti R
    Mol Neurobiol; 2016 Sep; 53(7):4833-64. PubMed ID: 26351077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease.
    El Kadmiri N; Zaid N; Zaid Y; Tadevosyan A; Hachem A; Dubé MP; Hamzi K; El Moutawakil B; Slassi I; Nadifi S
    Neuroscience; 2014 Jun; 269():215-22. PubMed ID: 24704512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.
    Sherman K; Shaw LK; Champion K; Caldeira F; McCaskill M
    J Behav Med; 2015 Oct; 38(5):706-14. PubMed ID: 25813985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes and knowledge about genetic testing before and after finding the disease-causing mutation among individuals at high risk for familial, early-onset Alzheimer's disease.
    Marcheco-Teruel B; Fuentes-Smith E
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):121-5. PubMed ID: 19309285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?
    Arribas-Ayllon M
    Br Med Bull; 2011; 100():7-21. PubMed ID: 21672937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Playing a part in research? University students' attitudes to direct-to-consumer genomics.
    Vayena E; Ineichen C; Stoupka E; Hafen E
    Public Health Genomics; 2014; 17(3):158-68. PubMed ID: 24777115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.
    Goldman JS; Van Deerlin VM
    Mol Diagn Ther; 2018 Oct; 22(5):505-513. PubMed ID: 29971646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes and knowledge about presymptomatic genetic testing among individuals at high risk for familial, early-onset Alzheimer's disease.
    Marcheco B; Bertoli AM; Rojas I; Heredero L
    Genet Test; 2003; 7(1):45-7. PubMed ID: 12820702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personal utility is inherent to direct-to-consumer genomic testing.
    Chung MW; Ng JC
    J Med Ethics; 2016 Oct; 42(10):649-52. PubMed ID: 27250638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Personal genomics for Alzheimer's disease].
    Kuwano R; Hara N
    Brain Nerve; 2013 Mar; 65(3):235-46. PubMed ID: 23475515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in genetic testing for Alzheimer's disease.
    Howard KL; Filley CM
    Rev Neurol Dis; 2009; 6(1):26-32. PubMed ID: 19367221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease.
    van der Cammen TJ; Croes EA; Dermaut B; de Jager MC; Cruts M; Van Broeckhoven C; van Duijn CM
    J Am Geriatr Soc; 2004 Dec; 52(12):2110-3. PubMed ID: 15571552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into genetic aspects of Alzheimer's disease. Does genetic information make a difference in clinical practice?
    Blacker D
    Postgrad Med; 2000 Oct; 108(5):119-22, 125-6, 129. PubMed ID: 11043085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward more predictive genetic mouse models of Alzheimer's disease.
    Onos KD; Sukoff Rizzo SJ; Howell GR; Sasner M
    Brain Res Bull; 2016 Apr; 122():1-11. PubMed ID: 26708939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study.
    Koeller DR; Uhlmann WR; Carere DA; Green RC; Roberts JS;
    J Genet Couns; 2017 Dec; 26(6):1270-1279. PubMed ID: 28512697
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.